The Scientist

» archaeology, microbiology and disease/medicine

Most Recent

image: Natural Opioids Linked to Chronic Pain

Natural Opioids Linked to Chronic Pain

By | September 19, 2013

The body’s own pain-quelling system may be at the root of chronic pain and symptoms of opioid withdrawal, according to a new study in mice.

0 Comments

image: Focus on the Host

Focus on the Host

By | September 18, 2013

A patient response-based gene expression signature can distinguish respiratory infections caused by viruses from those of bacterial or fungal origin.

1 Comment

image: CDC Charts Antibiotic Resistance Threat

CDC Charts Antibiotic Resistance Threat

By | September 16, 2013

The agency estimates that at least 23,000 people in the U.S. die each year as a result of antibiotic-resistant infections. 

0 Comments

image: Golden Goose Awards Given Again

Golden Goose Awards Given Again

By | September 12, 2013

Researchers behind high-impact studies that at first seemed obscure are honored in another round of prizes.

0 Comments

image: Obesity via Microbe Transplants

Obesity via Microbe Transplants

By | September 5, 2013

Germ-free mice gain weight when transplanted with gut microbes from obese humans, in a diet-dependent manner.

7 Comments

image: Decoding Drug-Resistant TB

Decoding Drug-Resistant TB

By | September 1, 2013

Researchers characterize drug-resistant tuberculosis by analyzing the genomes of more than 500 Mycobacterium tuberculosis isolates from around the world.

0 Comments

image: A Bone-Deep Kinship

A Bone-Deep Kinship

By | September 1, 2013

A Neanderthal rib fragment provides conclusive evidence that the ancient hominins were susceptible to a benign bone tumor of modern humans.

0 Comments

Contributors

By | September 1, 2013

Meet some of the people featured in the September 2013 issue of The Scientist.

0 Comments

image: Going Viral

Going Viral

By | September 1, 2013

Bacteriophages shuttle genes between diverse ecosystems.

1 Comment

image: Remaking a Classic

Remaking a Classic

By | September 1, 2013

Companies are bursting at the seams with tools to engineer pharma’s next magic bullet: the new and improved antibody.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech